The German biotechnology firm BioNTech, a name synonymous with the rapid development of the world’s first widely authorized mRNA COVID-19…
Read More
SK bioscience and VECOL Forge Strategic Partnership to Bolster Vaccine Self-Sufficiency in Colombia
SK bioscience has signed a significant vaccine technology transfer and manufacturing agreement with Colombia’s state-owned pharmaceutical company, VECOL. This collaboration…
Read More
BioNTech’s Dramatic Pivot: From €19B COVID Vaccine Fortunes to 1,860 Job Cuts and a €16.8B Oncology Bet
The German biotechnology powerhouse BioNTech, once synonymous with its groundbreaking COVID-19 vaccine Comirnaty, is undergoing a profound strategic transformation, shedding…
Read More
TWiV 1292: Clinical Update with Dr. Daniel Griffin Examines Public Health Decline, Vaccine Policy Shifts, and Resurgent Infectious Diseases
In a recent clinical update on the "This Week in Virology" (TWiV) podcast, Dr. Daniel Griffin and host Vincent Racaniello…
Read More
BioNTech Pivots Dramatically to Oncology Amidst Waning Vaccine Revenue and Federal Shift, Cutting 1,860 Jobs and Investing €16.8 Billion in Cash
The German biotechnology powerhouse BioNTech, once synonymous with its groundbreaking COVID-19 vaccine, Comirnaty, is undergoing a profound strategic transformation, shedding…
Read More
Mass Spectrometry: The Unsung Hero Revolutionizing Vaccine Development and Global Health Security
As World Immunization Week recently concluded, underscoring the vital importance of vaccination in public health, the scientific community is now…
Read More
Researchers at the University of Nebraska–Lincoln Develop Promising New Vaccine Against Bird Flu
A groundbreaking vaccine platform, meticulously engineered to provide robust protection against multiple strains of highly pathogenic avian influenza (HPAI) H5N1,…
Read More
TWiV 1290: Clinical Update with Dr. Daniel Griffin Explores Screwworm, Shingles Vaccine’s Anti-Aging Potential, and Critical Public Health Data.
In a recent episode of "This Week in Virology" (TWiV), Dr. Daniel Griffin provided his weekly clinical update, delving into…
Read More
FDA Reverses Course, Agrees to Review Moderna’s mRNA Flu Vaccine
The U.S. Food and Drug Administration (FDA) has officially reversed its earlier decision regarding Moderna’s investigational mRNA influenza vaccine (mRNA-1010),…
Read More
Groundbreaking Nanodisc Platform Unveils Unprecedented Insights into Viral Protein-Antibody Interactions, Promising Accelerated Vaccine Development
A pioneering scientific breakthrough has emerged from Scripps Research in California, USA, in collaboration with IAVI (New York, USA) and…
Read MoreYOU MAY HAVE MISSED
